Search | WHO COVID-19 Research Database

Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practice.

Marniquet, M-E; Seneschal, J; Darrigade, A-S; Staumont-Sallé, D; Jachiet, M; Nosbaum, A; Tauber, M; Abasq, C; Ferrier Le Bouedec, M-C; Droitcourt, C; Aubert, H; Bernier, C; Soria, A; Raison-Peyron, N; Tétart, F; Aubin, F; Viguier, M; Valois, A; Kupfer-Bessaguet, I; Goronflot, T; Barbarot, S.

Br J Dermatol ; 186(4): 733-735, 2022 04.

Article in English | MEDLINE | ID: covidwho-1799276

Subject(s)

Dermatitis, Atopic , Adult , Antibodies, Monoclonal, Humanized/adverse effects , Dermatitis, Atopic/drug therapy , Humans , Severity of Illness Index , Treatment Outcome

Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic.

Moghadam, P; Frumholtz, L; Jaume, L; De Masson, A; Jachiet, M; Begon, E; Sulimovic, L; Petit, A; Bachelez, H; Bagot, M; Bouaziz, J-D; Cassius, C.

J Eur Acad Dermatol Venereol ; 35(9): e566-e568, 2021 09.

Article in English | MEDLINE | ID: covidwho-1243613

Subject(s)

COVID-19 , Chilblains , Chilblains/diagnosis , Chilblains/epidemiology , Humans , Pandemics , Recurrence , SARS-CoV-2

Prolonged positive SARS-CoV-2 RT-PCR in cancer outpatients requires specific reorganization of cancer centres

Aguinaga, L.; Ursu, R.; Legoff, J.; Delauguerre, C.; Nguyen, O.; Harel, S.; Royer, B.; sebert, M.; Jachiet, M.; Lebbé, C.; Bonnet, C.; Brice, P.; Fenaux, P.; Plaud, B.; Aparicio, T..

Annals of Oncology ; 31:S1010, 2020.

Article in English | EMBASE | ID: covidwho-803939

Vascular skin symptoms in COVID-19: a French observational study.

Bouaziz, J D; Duong, T A; Jachiet, M; Velter, C; Lestang, P; Cassius, C; Arsouze, A; Domergue Than Trong, E; Bagot, M; Begon, E; Sulimovic, L; Rybojad, M.

J Eur Acad Dermatol Venereol ; 34(9): e451-e452, 2020 Sep.

Article in English | MEDLINE | ID: covidwho-125459

Subject(s)

COVID-19/complications , Skin Diseases, Vascular/complications , COVID-19/virology , France , Humans , SARS-CoV-2/isolation & purification

Subject(s)

Subject(s)

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL